For example, the addition of VC may enhance the efficacy of combined anti-CTLA-4 and anti-PD-1 blockade against tumors [47, 48], while in vitro studies have found that high doses of VC may target mitochondria, which in turn leads to cancer stem cell death [49]. The gene discussed is CTLA4; the disease is cancer.